Showing results (251-260 of 275) with videos related to
Sort By:
Pageof 28
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.The Journal of Clinical Investigation|May 2, 2022
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancerUta M Demel, Marlitt Böger, Schayan Yousefian, et al.Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.Biorxiv : the Preprint Server for Biology|June 19, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.Cancer Discovery|October 16, 2020
Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of OriginElisa Espinet, Zuguang Gu, Charles D Imbusch, et al.Cancer Cell|March 4, 2022
The proteogenomic subtypes of acute myeloid leukemiaAshok Kumar Jayavelu, Sebastian Wolf, Florian Buettner, et al.Nature Cancer|January 3, 2025
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signalingRoberto Würth, Elisa Donato, Laura L Michel, et al.Science Signaling|February 20, 2024
Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunityFrancis Baumgartner, Stefanos A Bamopoulos, Laura Faletti, et al.Molecular Cell|November 15, 2024
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistanceZhiyi Chen, Alex Inague, Kamini Kaushal, et al.Pageof 28